James A. Goldstein

James A. Goldstein

Auto-generated profile, based on publicly available information

James A. Goldstein

Department of Cardiovascular Medicine Beaumont Health System Royal Oak Michigan USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2000 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
JGJames A. Goldstein
James A. Goldstein
DDDemetris Demetriou
Demetris Demetriou
CGCindy L. Grines
Cindy L. Grines
MPMark Pica
Mark Pica
MSMazen Shoukfeh
Mazen Shoukfeh
WOWilliam W. O'Neill
William W. O'Neill
Acute myocardial infarction is believed to be caused by rupture of an unstable coronary-artery plaque that appears as a single lesion on angiography. However, plaque instability might be caused by pathophysiologic processes, such as inflammation, that exert adverse effects throughout the coronary vasculature and that therefore result in multiple unstable lesions.

22 November 2004 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
JGJames A. Goldstein
James A. Goldstein
SBStephen Balter
Stephen Balter
MCMichael Cowley
Michael Cowley
JHJohn Hodgson
John Hodgson
LKLloyd W. Klein
Lloyd W. Klein

1 September 2002 in JACC
Verified
Journal Article
Closed access
JGJames A Goldstein
James A Goldstein

1 October 2011 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
JGJames A. Goldstein
James A. Goldstein
BMBrijeshwar Maini
Brijeshwar Maini
SDSimon R. Dixon
Simon R. Dixon
EBEmmanouil Brilakis
Emmanouil Brilakis
CGCindy L. Grines
Cindy L. Grines
MKMorton J. Kern
Morton J. Kern
Background—: Percutaneous coronary intervention (PCI) is associated with periprocedural myocardial infarction (MI) in 3% to 15% of cases (depending on the definition used). In many cases, these MIs result from distal embolization of lipid-core plaque (LCP) constituents. Prospective identification of LCP with catheter-based near-infrared spectroscopy (NIRS) may predict an increased risk of periprocedural MI and facilitate development of preventive measures. Methods and Results—: The present study analyzed the relationship between the presence of a large LCP (detected by NIRS) and periprocedural MI. Patients with stable preprocedural cardiac biomarkers undergoing stenting were identified from the COLOR Registry, an ongoing prospective observational study of patients undergoing NIRS before PCI. The extent of LCP in the treatment zone was calculated as the maximal lipid-core burden index (LCBI) measured by NIRS for each of the 4-mm longitudinal segments in the treatment zone. A periprocedural MI was defined as new cardiac biomarker elevation above 3× upper limit of normal. A total of 62 patients undergoing stenting met eligibility criteria. A large LCP (defined as a maxLCBI 4 mm ≥500) was present in 14 of 62 lesions (22.6%), and periprocedural MI was documented in 9 of 62 (14.5%) of cases. Periprocedural MI occurred in 7 of 14 patients (50%) with a maxLCBI 4 mm ≥500, compared with 2 of 48 patients (4.2%) patients with a lower maxLCBI 4 mm ( P =0.0002). Conclusions—: NIRS provides rapid, automated detection of extensive LCPs that are associated with a high risk of periprocedural MI, presumably due to embolization of plaque contents during coronary intervention.

1 February 2012 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
RMRyan D. Madder
Ryan D. Madder
JSJames L. Smith
James L. Smith
SDSimon R. Dixon
Simon R. Dixon
JGJames A. Goldstein
James A. Goldstein
Background—: Whereas acute coronary syndromes (ACS) typically develop from the rupture of lipid core plaque (LCP), lesions causing stable angina are believed to be composed of fibrocalcific plaque. In this study, intracoronary near-infrared spectroscopy (NIRS) was used to determine the frequency of LCP at target and remote sites in patients with ACS versus those with stable angina. Methods and Results—: The study was performed in patients having ≥1 target lesion identified by invasive angiography who also underwent NIRS before intervention. LCP was defined as a 2-mm segment on the NIRS block chemogram having a strong positive reading indicated by a bright-yellow color. Patients with ACS and those with stable angina were compared for the frequency of LCP at target and remote sites. Among 60 patients (46.7% with ACS) undergoing invasive angiography and NIRS, 68 target lesions were identified. Although target lesions in patients with ACS were more frequently composed of LCP than targets in patients with stable angina (84.4% versus 52.8%, P =0.004), approximately one half of target lesions in patients with stable angina contained LCP. LCPs anatomically remote from the target lesion were frequent in patients with ACS and less common in patients with stable angina (73.3% versus 17.6%, P =0.002). Conclusions—: Target lesions responsible for ACS were frequently composed of LCP; in addition, LCPs often were found in remote, nontarget areas. Both target and remote LCPs were more common in patients with ACS than in those with stable angina. Approximately one half of target lesions in stable patients were also composed of LCP.

1 September 2004 in Current Problems in Cardiology
Verified
Journal Article
Closed access
JGJames A. Goldstein
James A. Goldstein